ArticleInternational ophthalmology2026
Comparison of visual outcomes of phakic intraocular lens implantation in keratoconus and normal eyes.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo Compare the visual outcomes of posterior chamber phakic intraocular lens (PCpIOL) implantation in keratoconus (KC) and normal eyes.
methodsPatients with KC (cases) and normal eyes (controls) who underwent PCpIOL implantation were analyzed. Eyes with stable KC were included if they had a corrected distance visual acuity (CDVA) ≥ 20/50 and at least 6 months of followup. Pathologies other than KC were excluded. Outcomes such as uncorrected distance visual acuity (UDVA), residual sphere, cylinder, spherical equivalent (SE), predictability, efficacy and safety index were calculated. Adverse events if any were reported.
resultsTwenty-eight eyes of 16 patients were included as cases and 40 eyes of 21 patients served as controls. At 6-month follow-up there was no statistically significant difference between cases and controls in UDVA (p = 0.99), residual sphere (p = 0.36), cylinder (p = 0.09) and SE (p = 0.93). Safety index was 1.17 ± 0.36 and 1.15 ± 0.22 while efficacy index was 1.04 ± 0.32 and 0.93 ± 0.22 in the case and control group respectively. A total of 4 eyes, 2 each in both the groups required a second surgical intervention. Of these, 2 eyes required repositioning of rotated PCpIOL (1 in each group), 1 eye developed cataract in the controls group, and 1 eye had a high vault in the cases necessitating PCpIOL exchange.
conclusionsWe did not observe a statistically significant difference in visual and refractive outcomes between keratoconus and normal eyes following PCpIOL implantation.
Indexed as
Identifiers
42397455What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.